You sure you went back 8 years and couldn't find an NPAT higher than $3m? My 2011 NPAT was $33.6m (and FY10 was $18.2m). Probably also worth noting that they achieved those figures in their old Malaga plant, which has roughly half the capacity of their Henderson plant (which was commissioned in FY12).
At any rate, i'd suggest cash flow is probably the more appropriate thing to look at, given the value of a company is the expected future cash flows generated into perpetuity discounted back. MCE's cash flow and profitability have been significantly misaligned over the last 5 years as: 1) they've taken impairments along the way, 2) the P&L depreciation charge with respect to the Henderson plant significantly exceeds what they're spending in cash capex.
I think calling MCE 'speculation' is fair as it's ultimately exposed to the oil capex cycle coming back (and guessing where the oil capex cycle is going is speculation), but it's wrong to suggest this business can't generate very significant free cash flow relative to its current ~$43m EV.
- Forums
- ASX - By Stock
- MCE
- Ann: Investor Presentation Dec 17 Half Year Results
Ann: Investor Presentation Dec 17 Half Year Results, page-9
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MCE (ASX) to my watchlist
(20min delay)
|
|||||
Last
27.5¢ |
Change
0.045(19.6%) |
Mkt cap ! $72.45M |
Open | High | Low | Value | Volume |
26.0¢ | 29.0¢ | 26.0¢ | $57.59K | 205.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 7703 | 27.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
28.0¢ | 36500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 14995 | 0.290 |
1 | 8500 | 0.285 |
1 | 6500 | 0.280 |
1 | 15000 | 0.270 |
1 | 10000 | 0.265 |
Price($) | Vol. | No. |
---|---|---|
0.320 | 3031 | 1 |
0.340 | 3649 | 1 |
0.345 | 12762 | 1 |
0.350 | 98847 | 3 |
0.360 | 30000 | 1 |
Last trade - 15.48pm 25/11/2024 (20 minute delay) ? |
Featured News
MCE (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online